Brand Name Pharmaceutical Manufacturing in the US - Industry Market Research Report


March 18, 2013
45 Pages - SKU: IBSS5006549
License type:
Countries covered: United States

Brand Name Pharmaceutical Manufacturing in the US

With healthcare reform allowing more individuals to gain prescription coverage, brand-name pharmaceutical and medicine manufacturers will experience a boost in demand. Rising production of branded follow-on biologic drugs will be important in offsetting the effects of widespread patent expirations, though a major increase in taxes and discounts to fill the Medicare coverage gap threatens profit in the industry.

Pharmaceutical manufacturers develop prescription and over-the-counter products that are used to prevent or treat illnesses in humans or animals. Brand-name drugs and medication have patent protection. This industry does not include nutritional supplement or cosmetic product manufacturers.

This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.


Additional Information

MAJOR COMPANIES

GlaxoSmithKline PLC
Johnson & Johnson
Merck and Co. Inc.
Pfizer Inc.
Amgen
Eli Lilly & Company

More Prescription Drugs reports by IBISWorld

Brand Name Pharmaceutical Manufacturing in the US - Industry Risk Rating Report by IBISWorld
Industry Risk Ratings SynopsisThis Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Brand Name Pharmaceutical Manufacturing in the US industry. ...
Contract Research Organizations in the US - Industry Market Research Report by IBISWorld
Contract Research OrganizationsThe industry experienced aggressive growth during the past five years as operators have worked to provide clients with a full-service experience, from product ...
Pharmaceuticals Wholesaling in Australia - Industry Market Research Report by IBISWorld
Pharmaceuticals Wholesaling in AustraliaThe industry comprises companies that wholesale pharmaceutical products, including prescription drugs and over-the-counter medicines. The products are obtained from the relevant upstream ...
Obesity Medication Manufacturing in the US - Industry Market Research Report by IBISWorld
Obesity Medication ManufacturingThe industry is growing along with Americans' waistlines. While the industry has benefited from rising obesity rates and other demographic trends, regulatory approval ...
See all reports like this >>

More United States Prescription Drugs reports

United States Pharmaceuticals and Healthcare Report Q2 2013 by Business Monitor International
BMI View: For years to come, the US pharmaceutical market will remain the most attractive todrugmakers. Considerable absolute sales figures and high expected growth are ...
Brand Name Pharmaceutical Manufacturing in the US - Industry Risk Rating Report by IBISWorld
Industry Risk Ratings SynopsisThis Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Brand Name Pharmaceutical Manufacturing in the US industry. ...
Cough, Cold and Allergy (Hay Fever) Remedies in the US by Euromonitor International
Executive Summary TRENDS Cough, cold and allergy (hay fever) remedies faced several challenges in 2012. First, the 2011-2012 flu season was unusually mild. Warmer ...
The U.S. Market for Urgent Care Centers by Kalorama Information
Urgent care centers in the United States provide an increasingly important option between a physician’s office and a hospital emergency room. They provide ...
See all reports like this >>

More United States reports

The 2013-2018 Outlook for Relish in the United States by Icon Group International, Inc.
This econometric study covers the latent demand outlook for relish across the states and cities of the United States. Latent demand (in millions of U.S. ...
The 2013-2018 Outlook for Indian Breads in the United States by Icon Group International, Inc.
This econometric study covers the latent demand outlook for Indian breads across the states and cities of the United States. Latent demand (in millions of ...
D&B Country RiskLine Report: The United States of America by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: The United States of America by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
See all reports like this >>